Today’s top gainers include the company Novartis AG (NYSE:NVS) which is in the industry Drug Manufacturers – Major, gaining 0.97% today. In the last week its performance is -0.65%, and -8.08% for the past quarter. Currently, Novartis AG, NVS has a target price of 95.16, so today’s gain of 0.97% is a significant step towards its target price. The GAP today is therefore 0.41%.
Novartis AG (NYSE:NVS), has a market cap of 198301.45, and is based in Switzerland. Insider ownership is at 9.30%, and institutional ownership is 10.00%.
At the current price of 76.31, it has a dividend yield of 3.56%, and its target price is 95.16. This is with a profit margin of 13.60%, and total debt/equity of 0.36. Novartis AG (NYSE:NVS) has a P/E of 27.6, as well as a forward P/E of 15.19.
With a current EPS of 2.77, and a forecasted EPS growth for next year at 6.33%,Novartis AG (NYSE:NVS) has had a EPS growth for the past five years at -7.50%. For the next five years EPS growth is projected to be 6.03%.
Performance for the year is -15.76%. Since its IPO date on 11/7/1996, the total performance to date is -7.85%.
Volume today for Novartis AG (NYSE:NVS), is 2895500, while its average volume is 1606.45. Whilst the total gain today was 0.97%, it did have a day high of -8.04%.
Volatility for this week has been at 1.53%, and 1.07% for the month. The 52-week low for Novartis AG, NVS has been 10.81%, while the 52-week-high has reached -16.22%.
Looking at its return of investments, which is 7.80%, and its return on assets is 5.10%. Novartis AG (NYSE:NVS) has an operating margin of 16.90%. With a sales growth of -1.70% quarter over quarter. Bearing in mind that Novartis AG, NVS is in the sector Healthcare, its long-term debt/equity is 0.22, and has a current ratio of 0.9 and 0.6 for quick ratio.
So what is the value of Novartis AG? Well its PEG is 4.58, and the P/S is 3.98, along with a P/B of 2.51. Meanwhile it has a p/cash of *TBA.